Silverback Therapeutics I... (SBTX)
NASDAQ: SBTX
· Real-Time Price · USD
5.87
0.06 (1.03%)
At close: Nov 09, 2022, 6:00 AM
Silverback Therapeutics Revenue
Silverback Therapeutics reported an annual revenue of $89.15M, reflecting a 297063.33% growth. For the quarter ending March 31, 2025, Silverback Therapeutics generated $7.97M in revenue.
Revenue (ttm)
89.15M
Revenue Growth
297063.33%
Price / Sales Ratio
6.38
Revenue / Employee
990.54K
Employees
90
Market Cap
550.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 89.15M | +297063.33% |
| Dec 31, 2023 | 30K | -97.72% |
| Dec 31, 2022 | 1.32M | -76.10% |
| Dec 31, 2021 | 5.51M | -69.13% |
| Dec 31, 2020 | 17.84M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |